The activation of glutamate receptors, clearly observed in ALS patients, could enhance BDNF production, which in turn could trigger a further release of glutamate, perturbing neuron activity, increasing glutamate excitotoxicity and resulting in neuronal death [4]. This evidence concerns the gene BDNF and amyotrophic lateral sclerosis.